Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > New Press Release - Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development
View:
Comment by lscfa on Mar 13, 2024 11:23am
How about some damn details.  VM pays RC a royalty for what exactly? A percentage of gross revenues? Who does what (pays for what) in the way of drug development? "This milestone signifies the execution of a royalty agreement that solidifies the exclusive development and license agreement between the parties and it further reinforces Voyageur’s commitment to pioneering sustainable ...more  
Comment by whitenorth72 on Mar 13, 2024 12:31pm
Just guessing but maybe NDAs were signed. From what I have gathered is Rain cage is trying hard to stay under  the radar until they are ready to fully promo. Im very happy about VM and RCs relationship and I believe we are in the right place at the right time. Like I said just a wishful guess.
Comment by WarrantOfficer on Mar 13, 2024 3:55pm
I agree whitenorth72. The pharma field is frightening competitive. Releasing details of Royalty Agreements could turn catastrophic. Competitiors always ready to pounce. Patiently waiting for release of barium sulphate product line in the next couple of months. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1